Page last updated: 2024-10-29

ketamine and Diseases in Twins

ketamine has been researched along with Diseases in Twins in 1 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Diseases in Twins: Disorders affecting TWINS, one or both, at any age.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schmidt, J1
Kroeber, S1
Irouschek, A1
Birkholz, T1
Schroth, M1
Albrecht, S1

Other Studies

1 other study available for ketamine and Diseases in Twins

ArticleYear
Anesthetic management of patients with ornithine transcarbamylase deficiency.
    Paediatric anaesthesia, 2006, Volume: 16, Issue:3

    Topics: Anesthesia, General; Anesthetics, Combined; Catheterization, Central Venous; Catheters, Indwelling;

2006